Dainippon Closing In On Cell Therapy Specialist Cynata

 
• By Ian Haydock

Australian venture with Phase II-ready cell therapy in sights of Sumitomo Dainippon as Japanese firm looks to build regenerative medicine interests and pipeline ahead of major expiry.

Mesenchymal cell
Australian Stem Cell Venture Cynata Attracts Interest • Source: Shutterstock

More from Deals

More from Business